AlenCiken

$CANF Signs $42.7 Million Out-Licensing Deal with Ewopharma

AMEX:CANF   Can-Fite Biopharma Ltd Sponsored
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

Swiss Ewopharma to market Piclidenoson and Namodenoson in Central Eastern Europe (CEE)

$2.25 million upfront payment with an additional $40.45 million for regulatory & sales milestones and 17.5% royalties are included

https://finance.yahoo.com/news/fite-sign...

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter